Patents Assigned to HANGZHOU EXEGENESIS BIO LTD.
  • FUSION MOLECULES TARGETING VEGF AND ANGIOPOIETIN AND USES THEREOF
    Publication number: 20240190943
    Abstract: A polypeptide comprising two or three VEGF binding domains; and a domain that binds to an angiopoietin, and a gene therapy for delivering such a polypeptide.
    Type: Application
    Filed: March 30, 2022
    Publication date: June 13, 2024
    Applicant: HANGZHOU EXEGENESIS BIO LTD.
    Inventors: Guojie YE, Zhenhua WU, Lijun WANG, Li DAI
  • NUCLEIC ACID CONSTRUCTS AND USES THEREOF FOR TREATING SPINAL MUSCULAR ATROPHY
    Publication number: 20230293730
    Abstract: A nucleic acid comprising a first nucleic acid region comprising a nucleic acid sequence encoding a SMN protein or variant thereof; and a second nucleic acid region comprising one or more target segment(s) of one or more endogenous microRNA(s), wherein the second nucleic acid region is at 3? of the first nucleic acid region.
    Type: Application
    Filed: August 4, 2021
    Publication date: September 21, 2023
    Applicant: HANGZHOU EXEGENESIS BIO LTD.
    Inventors: Peixin ZHU, Guojie YE, Zhenhua WU, Lijun WANG